GALLAHUE KIERAN 4
4 · Edwards Lifesciences Corp · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Gallahue Kieran
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-23$36.86/sh+7,056$260,107→ 10,757 total - Gift
Common Stock
2024-02-23−7,056→ 3,701 total - Gift
Common Stock
2024-02-23+7,056→ 70,277 total(indirect: By Trust) - Exercise/Conversion
Director Stock Option (Right to Acquire)
2024-02-23−7,056→ 0 totalExercise: $36.86From: 2017-05-12Exp: 2024-05-11→ Common Stock (7,056 underlying) - Sale
Common Stock
2024-02-23$87.61/sh−3,058$267,911→ 67,219 total(indirect: By Trust)
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.